
Usually, an impairment loss does not reduce EBITDA, as long as the company's EBITDA measure leaves impairment out. But EBITDA is not defined by Ind AS or IFRS. So the answer depends on how each company calculates and presents it. Impairment does reduce reported operating profit (EBIT), profit before tax and the carrying amount of the asset.
For CFOs, investors and valuers, the bigger question is not whether to add impairment back. It is why the impairment happened, and whether it signals weaker future cash flow.
Key points
- Ind AS 36 and IAS 36 require an impairment loss when an asset's carrying amount is above its recoverable amount.
- Recoverable amount is the higher of value in use (VIU) and fair value less costs of disposal (FVLCD).
- Impairment is a non-cash charge, but it lowers the asset's book value.
- It reduces EBIT and profit before tax. Its effect on EBITDA depends on the EBITDA definition.
- A ₹10 crore impairment may be added back to adjusted EBITDA if it is truly one-off. But do not ignore what caused it.
What is an impairment loss?
An impairment loss arises when an asset is carried in the books at more than it can recover. The same holds for a cash-generating unit (CGU).
Put simply, the asset's book value can no longer be supported by what it will earn or sell for. So it must be written down.
Under Ind AS 36 (Impairment of Assets), the recoverable amount is the higher of:
- Fair value less costs of disposal (FVLCD), and
- Value in use (VIU)
The recoverable amount may be below the carrying amount. If so, the gap is as a rule booked as an impairment loss.
A simple example:
- Carrying amount: ₹10 crore
- Value in use: ₹7 crore
- Fair value less costs of disposal: ₹7.5 crore
The recoverable amount is ₹7.5 crore, the higher of the two. Impairment loss = ₹10 crore − ₹7.5 crore = ₹2.5 crore. The carrying amount drops by ₹2.5 crore.
Does impairment affect EBITDA?
It does not have to, but it depends on how EBITDA is defined.
EBITDA means earnings before interest, taxes, depreciation and amortisation. Impairment is not one of those four items. And EBITDA is not a standard Ind AS or IFRS measure.
So two cases arise:
- A company may show EBITDA that already leaves out impairment. This is common when impairment sits on its own line.
- Another company or analyst may start from a profit figure that includes impairment. They then add it back to get adjusted EBITDA.
Saying impairment "never affects EBITDA" is too broad. The right steps are:
- Check the starting profit figure.
- Check where the impairment was booked.
- Check the company's EBITDA definition.
- Then decide whether an adjustment is needed.
For valuers, impairment can be left out of normalised earnings when it is non-cash and one-off. But its cause should still shape cash flow forecasts and risk.
How does impairment affect each financial measure?
| Measure | Typical effect | Why it matters |
|---|---|---|
| EBITDA | Usually no direct effect | Usually excluded, but it depends on the EBITDA definition and any adjustments |
| EBIT / operating profit | Usually falls | The loss reduces reported operating profit |
| Profit before tax | Usually falls | The loss reduces accounting profit |
| Net profit (PAT) | Usually falls, after tax effects | Depends on the amount and any current or deferred tax effect |
| Operating cash flow | No direct cash outflow | It is a non-cash entry, but its cause may mean weaker cash flow ahead |
| Asset carrying amount | Falls | The asset or CGU is written down to its recoverable amount |
The key point: an impairment can be non-cash today but matter a lot tomorrow. A write-down from a passing accounting event may mean little. But the cause may be falling demand, old technology, a lost customer or thin margins. Then it may be a sign of weaker cash flow to come. That matters greatly in valuation.
How does a ₹10 crore impairment flow through the numbers?
| Item | Amount |
|---|---|
| Revenue | ₹100 crore |
| Operating costs before D&A and impairment | ₹60 crore |
| EBITDA before impairment | ₹40 crore |
| Depreciation and amortisation | ₹8 crore |
| EBIT before impairment | ₹32 crore |
| Impairment loss | ₹10 crore |
| EBIT after impairment | ₹22 crore |
If the company's EBITDA excludes the ₹10 crore impairment, EBITDA stays at ₹40 crore. EBIT falls from ₹32 crore to ₹22 crore.
An analyst may start from a profit figure that includes the impairment. If so, they must tie the numbers up with care. Only then can they call the result EBITDA or adjusted EBITDA. Do not add the ₹10 crore back to an EBITDA figure that already excluded it. That would count it twice.
Where does impairment appear in the accounts?
An impairment loss is usually booked straight to profit or loss. One exception is an asset carried at a revalued amount, which follows its own rules. It also reduces the asset's carrying amount on the balance sheet.
How it is shown can depend on:
- The type of asset
- How material it is
- The company's accounting policies
- How the statements are laid out
- Disclosure rules
So read both the main statements and the notes. Do not assume every impairment sits on the same line.
Is impairment a non-cash expense?
Yes. Booking an impairment loss does not usually involve paying cash at that moment. That is one reason analysts may adjust for it in normalised earnings.
But non-cash does not mean unimportant. An impairment may point to:
- Falling future cash flow
- Lost customers or contracts
- Out-of-date technology
- Assets used below capacity
- Weaker markets
- Harmful rule changes
- Lower profit
- A failed acquisition
- A CGU whose economics are getting worse
For valuation, the reason for the impairment often matters more than the entry itself.
When must companies test for impairment?
Under Ind AS 36, at the end of each reporting period, a company checks for signs that an asset may be impaired. If there are signs, it estimates the recoverable amount. Some assets, such as goodwill from an acquisition and certain intangibles, must be tested every year.
Outside signs:
- A big fall in the asset's market value
- A worse economy or industry
- Tech disruption
- Rule changes
- Higher interest rates or market returns
- Weaker market conditions
Inside signs:
- Physical damage
- Technical or commercial obsolescence
- Assets used below capacity
- Plans to close or restructure operations
- Results well below plan
- Evidence that the asset is earning less
Management should look at the real facts for each asset or CGU, not treat the test as a box-ticking exercise.
How is an impairment test done?
Step 1: find the carrying amount. This is the value at which the asset or CGU sits in the accounts.
Step 2: work out value in use. VIU is the present value of the cash the asset or CGU is expected to earn. It needs a view on many things. These are sales, margins, capital spending and working capital. They are also long-term growth, useful life and the discount rate.
Step 3: work out fair value less costs of disposal. FVLCD is the asset's fair value minus the cost of selling it. It may draw on market deals or on firms of the same kind. It may draw on proof for the asset itself or on other valuation inputs.
Step 4: compare. The recoverable amount is the higher of VIU and FVLCD. If the carrying amount is higher than the recoverable amount, the excess is the impairment loss.
Example:
- Carrying amount of the CGU: ₹150 crore
- Value in use: ₹120 crore
- Fair value less costs of disposal: ₹130 crore
- Recoverable amount: ₹130 crore
- Impairment loss: ₹150 crore − ₹130 crore = ₹20 crore
The sum looks simple. In practice, setting VIU and FVLCD takes a lot of valuation judgement.
What is a cash-generating unit (CGU)?
A CGU is the smallest group of assets that earns cash largely on its own, apart from other assets.
This matters when a single asset does not earn its own cash. A machine on a production line, for example, may not produce cash by itself. Then the test happens at the CGU level.
A wrong CGU can change a lot. It can change the cash flow forecast and how goodwill is shared out. It can change the recoverable amount, the result of the test and the notes to the accounts.
What about goodwill impairment?
Goodwill impairment is a non-cash write-down. It happens when the recoverable amount of the CGU holding the goodwill no longer supports its book value. Its effect on EBITDA, again, depends on the EBITDA definition.
Investors should look closely at goodwill impairment. It can show that the case for an earlier acquisition has weakened. Causes include:
- The acquisition doing worse than planned
- Losing key customers
- Lower margins
- Higher discount rates
- Slower industry growth
- New competition
- Changes to long-term forecasts
So adding goodwill impairment back to adjusted earnings does not mean ignoring its cause.
How is impairment different from depreciation?
| Impairment | Depreciation | |
|---|---|---|
| Purpose | Records a fall when an asset's book value cannot be recovered | Spreads an asset's cost over its useful life |
| Timing | Triggered by warning signs; some assets need a yearly test | Booked steadily over the asset's life |
| Nature | Can arise suddenly when things change | Expected as normal accounting |
| Cash effect when booked | Usually non-cash | Non-cash |
| EBITDA treatment | Usually excluded, but depends on the definition | Excluded by definition |
| EBIT effect | Usually reduces EBIT | Reduces EBIT |
So a company can report steady EBITDA while taking a big impairment. That does not mean its economics are unchanged.
Can an impairment loss be reversed?
Under Ind AS 36, an impairment loss on some assets can be reversed. This can happen when the estimates behind the recoverable amount change. The standard sets limits on it.
Goodwill is different. A goodwill impairment is never reversed.
This matters when you study past earnings. A write-down and a later reversal can both move reported profit. Yet operating cash flow may not change at all. Understand the assumptions; do not just add or subtract the items.
How does impairment affect business valuation?
An impairment does not cut enterprise value by the exact amount of the charge. Enterprise value depends on what the business will earn. But an impairment can reveal changes in the assumptions behind that value, such as:
- Lower expected revenue
- Falling margins
- Lower growth
- Higher risk
- Assets used less
- Higher discount rates
- A lower terminal value
All of these can also lower a DCF value. Read more on business valuation approaches.
Impairment and EV/EBITDA
Say a company has an enterprise value of ₹800 crore and steady EBITDA of ₹100 crore. Its EV/EBITDA is ₹800 crore ÷ ₹100 crore = 8.0x.
Now suppose an impairment is left out of EBITDA, but it reveals a lasting drop in future cash flow. Investors may cut the value they will pay. Enterprise value falls to ₹650 crore. EBITDA stays at ₹100 crore. EV/EBITDA is now 6.5x.
The impairment did not change EBITDA. But the facts behind it changed how the business was valued.
Should impairment always be added back to EBITDA?
Not automatically. It may be adjusted out of normalised earnings because it is non-cash and often one-off. But first check whether it was already excluded. Then ask:
- Has impairment already been left out of reported EBITDA?
- Is it truly one-off?
- What caused it?
- Does that cause affect future results?
- Are the cash flow forecasts in line with the impairment?
- Will future depreciation or amortisation change after the write-down?
- Is adjusted EBITDA used the same way across periods and peers?
An add-back that flatters EBITDA but ignores weaker economics can overstate value.
Does impairment affect future earnings?
Yes. After a write-down, the carrying amount is lower. Future depreciation or amortisation may be based on that lower figure, spread over the life the asset has left. So impairment can affect the accounts beyond the year it is booked.
CFOs and valuation teams should model:
- The immediate impairment charge
- The new carrying values
- Future depreciation and amortisation
- Deferred tax effects, where relevant
- Future earnings
- Valuation assumptions
Why does impairment matter to each stakeholder?
- CFOs and finance teams: accurate reporting, sound forecasts, the right CGUs and well-documented assumptions.
- Auditors: whether the inputs, forecasts, discount rates, growth rates and methods used by the managers are fair and backed by proof.
- Investors: what impairment says about asset quality, acquisitions and past growth claims.
- Lenders: asset cover, covenants, credit risk and future cash-earning power.
- Deal teams: past impairments may need to be taken out of maintainable EBITDA. But their causes still matter in due diligence.
When should you get independent valuation support?
Consider expert help when:
- Goodwill from an acquisition is material
- A business or CGU is underperforming
- Forecasts have fallen sharply
- A plant runs below capacity
- Technology has made assets obsolete
- Markets have worsened
- A big customer or contract has been lost
- The business has restructured
- Discount rates have changed a lot
- An asset has suffered physical or economic decline
- Management or auditors need strong support for VIU or FVLCD
A good impairment review shows a clear link. It runs from the forecasts and the market proof to the inputs, and then to the final recoverable amount.
What information is needed for an impairment test?
- Past financial statements
- Management forecasts, budgets and business plans
- Fixed asset details
- CGU details
- Acquisition papers and goodwill allocation
- Revenue and margin assumptions
- Capital spending and working capital forecasts
- Industry and market data
- Discount rate inputs
- Past impairment tests
- Management's strategic outlook
Gathering these early makes the test faster and avoids last-minute audit problems.
What should finance teams ask before an impairment test?
- Have things changed since the last period? Review internal results and outside market shifts.
- Are forecasts still realistic? Compare past forecasts with actual results. Repeated misses may call for new assumptions.
- Are the CGUs still right? Changes in structure, reporting or operations can change them.
- Are discount and growth rates current? The state of the market, risk-free rates, business risk and the outlook for growth all move the recoverable amount.
- Is there enough evidence? Back each major input with your own data, market data and sound valuation work.
What is the bottom line?
"Does impairment affect EBITDA?" has no simple yes or no answer. Impairment is usually non-cash, and many EBITDA measures exclude it. But since EBITDA has no standard definition, check the actual calculation.
What matters more is this. Impairment cuts EBIT and profit. It lowers asset values. It can also be a sign of weaker results ahead. So look beyond the add-back. Find out why it happened. Judge what it does to lasting cash flow. Keep the inputs for your impairment test and your valuation in step.
RNC Valuecon LLP gives independent help with impairment tests. We work out value in use and fair value less costs of disposal. We review CGUs. We also value goodwill and intangibles. See our valuation for impairment testing or discuss your requirement.
Frequently asked questions
Why is impairment excluded from EBITDA?+
EBITDA aims to show cash earnings from operations. It leaves out non-cash items such as depreciation, amortisation and impairment.
When is a valuation needed for impairment?+
You need one when there are signs that an asset or cash-generating unit is worth less than its book value. For goodwill, you need one each year under Ind AS 36.
Sources and standards
The regulators and standard setters whose rules apply to this topic. Rules change, so check the current text before relying on it.